Skip to content

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment

Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03959774
Acronym
E-SN@P PROJECT
Enrollment
119
Registered
2019-05-22
Start date
2020-12-30
Completion date
2023-12-30
Last updated
2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Lung Cancer

Keywords

Elderly population, digital monitoring

Brief summary

adherence of digital follow-up in a population of elderly patients.

Detailed description

The use of digital self-questionnaires adapted to elderly patients but also to BrC and Bac could detect the toxicities of chemotherapy and we formulate the hypothesis that the continuous monitoring of these different variables in elderly patients treated with chemotherapy is possible and acceptable to this population.

Interventions

DEVICEIPC NET

a digital pack with connected bracelet and connected balance will be given to the patient. IPC NET and Nokia Health applications will be downloaded. Pairing between connected objects and the smartphone will be done during the inclusion visit

Sponsors

Institut Paoli-Calmettes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 70 years, 2. Patient with an indication of adjuvant chemotherapy showing: * Breast cancer * Colorectal cancer * lung cancer 4\. WHO ≤ 3 (WHO index - World Health Organization) 5. Estimated life expectancy\> 6 months 6. patients with a smartphone or tablet with an internet connection. It can also be offered to patients whose primary caregiver or the person of trust (including the partner) has a smartphone, an internet connection or a tablet provided that he or she is present more than three times during the week. during chemotherapy to ensure smooth weekly data transfer and filling of questionnaires 7. Signed consent to participation 8. Affiliation to, or beneficiary of, a social security scheme

Exclusion criteria

1. Person in emergency situation, person of legal age subject to a legal protection measure (major under guardianship, guardianship or court order), or unable to express his / her consent 2. Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons 3. Contraindications to the procedure of the study: patient or caregiver living with a patient who does not have a smartphone with an internet connection (patient or caregiver living with a patient) 4. Concurrent participation in another clinical trial 5. Patient unable to understand the quality of life survey and Patient Reported Outcome

Design outcomes

Primary

MeasureTime frameDescription
demonstrate that the adherence rate of digital follow-up is greater than 70% in a population of elderly patients.12 months after the last chemotherapy received by the patientnumerical follow-up compliance rate, defined as the rate of patients who observed the following three rules during the entire course of adjuvant chemotherapy: a minimum weight per week, the wearing of the bracelet for three consecutive days per week, and the weekly response to the digital self-questionnaire. Failure to comply with at least one of these rules will be considered a failure.

Countries

France

Contacts

Primary ContactDominique GENRE, MD
drci.up@ipc.unicancer.fr33491223778

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026